| Overview |
| bsm-61752r-cy3-100ul |
| Nkx3.1 Recombinant Antibody, Cy3 Conjugated |
| WB, IF |
| Human |
| Specifications |
| Cy3 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human Nkx 3.1 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 4824 |
| Q99801 |
| Nucleus |
| NKX3; BAPX2; NKX3A; NKX3.1; NKX3-1. |
| Transcription factor, which binds preferentially the consensus sequence 5'-TAAGT[AG]-3' and can behave as a transcriptional repressor. Plays an important role in normal prostate development, regulating proliferation of glandular epithelium and in the formation of ducts in prostate. Acts as a tumor suppressor controlling prostate carcinogenesis, as shown by the ability to inhibit proliferation and invasion activities of PC-3 prostate cancer cells. |
| Application Dilution |
| WB |
1:300-5000 |
| IF |
|
Powered by Bioz